Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05594706

Anhydroglucitol in Children With Type 1 Diabetes

Sponsor: University Hospital, Geneva

View on ClinicalTrials.gov

Summary

The investigators will measure blood levels of 1,5-anhydroglucitol in children with type 1 diabetes and correlate them with parameters related to functional beta-cell mass in diabetic patients. The values will be compared to those obtained in healthy volunteers. Children with newly diagnosed diabetes as well as children with longstanding disease will be included. The aim of the study is to test the validity of 1,5-anhydroglucitol as a novel biomarker of beta-cell mass and function in type 1 diabetes.

Official title: Anhydroglucitol as a Measure of the Functional Beta-cell Mass in Children With Type 1 Diabetes - Pilot Study

Key Details

Gender

All

Age Range

2 Years - 18 Years

Study Type

OBSERVATIONAL

Enrollment

60

Start Date

2023-01-27

Completion Date

2026-12-31

Last Updated

2025-04-02

Healthy Volunteers

Yes

Interventions

OTHER

Measurement of blood levels of 1,5-anhydroglucitol

Measurement of blood levels of 1,5-anhydroglucitol

Locations (1)

University Hospital of Geneva

Geneva, Canton of Geneva, Switzerland